Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.
Autonomous AI diagnostic system that diagnoses diabetic retinopathy at the point of care
—
Digital Diagnostics makes LumineticsCore (formerly IDx-DR), the first FDA De Novo cleared autonomous AI diagnostic system. It analyzes retinal images captured with a Topcon TRC-NW400 fundus camera and returns a diagnostic result for more than mild diabetic retinopathy during the patient encounter, without physician overread. Digital Diagnostics publishes no public BAA, security certification, or pricing statements on its website.
Insilico Medicine is a clinical-stage generative AI drug discovery company. Its Pharma.AI platform, sold as stand-alone technology access or combined with discovery collaborations, includes PandaOmics for target discovery, Chemistry42 for generative molecule design, inClinico for clinical trial outcome prediction, and Science42 tools including the DORA research writing assistant. The company also advances its own AI-designed drug pipeline.
Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.